Page last updated: 2024-10-22

antipyrine and Pseudotumor Cerebri

antipyrine has been researched along with Pseudotumor Cerebri in 1 studies

Antipyrine: An analgesic and antipyretic that has been given by mouth and as ear drops. Antipyrine is often used in testing the effects of other drugs or diseases on drug-metabolizing enzymes in the liver. (From Martindale, The Extra Pharmacopoeia, 30th ed, p29)
antipyrine : A pyrazolone derivative that is 1,2-dihydropyrazol-3-one substituted with methyl groups at N-1 and C-5 and with a phenyl group at N-2.

Pseudotumor Cerebri: A condition marked by raised intracranial pressure and characterized clinically by HEADACHES; NAUSEA; PAPILLEDEMA, peripheral constriction of the visual fields, transient visual obscurations, and pulsatile TINNITUS. OBESITY is frequently associated with this condition, which primarily affects women between 20 and 44 years of age. Chronic PAPILLEDEMA may lead to optic nerve injury (see OPTIC NERVE DISEASES) and visual loss (see BLINDNESS).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Soriani, S1
Voghenzi, A1
Scorrano, M1

Other Studies

1 other study available for antipyrine and Pseudotumor Cerebri

ArticleYear
[Fontanelle bombée : the possible consequence of sulphenazone therapy].
    Minerva pediatrica, 1981, May-31, Volume: 33, Issue:10

    Topics: Antipyrine; Female; Fever; Humans; Infant; Pseudotumor Cerebri; Sulfamethoxypyridazine

1981